See this page online at: http://www.biotechfocus.com/2006issue10
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
Throwing Down The Gauntlet By Amber Lepage-Monette The Stiller Centre Prize wants to change commercialization in Canada
Peter Bruijns has big hopes for Canadian science. As president of the Stiller Centre for Technology Commercialization,Bruijns is looking to increase the number of inventions that are brought to market, and ultimately change the way commercialization is handled not only in Ontario, but in Canada as well. |
|
The Thrill Of Discovery-The Satisfaction Of Success By Denise Jillions StemPath's Michael Rudnicki, PhD paves the way in stem cell research
Most days Michael Rudnicki, PhD can be found in the bowels of his laboratory at the Ottawa Health Research Institute, guiding the research that has helped put Canada at the forefront of molecular medicine and on the verge of harnessing the capacity of stem cells for treating disease. |
|
The Importance of Sample Collection and Handling Methods In Biomarker Research By Kenneth R. Evans, PhD Despite its huge potential being touted enthusiastically by scientists, the media and regulatory bodies with equal degrees of optimism, the relatively new field of biomarker research still faces enormous and complex challenges.
|
|
Logistically Speaking By Paul Saratsiotis A Guide to Global Clinical Trial Coordination
The cost of bringing a new drug to market can now exceed 800 million dollars - triple the cost of ten years ago. |